Cargando…
MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and oligo-ovulation associated with insulin resistance (IR). Adipose-IR may underlie this PCOS phenotype and could contribute to IR by impairing insulin-mediated glucose uptake and/or lipogenesis, while diminishing insulin suppres...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550739/ http://dx.doi.org/10.1210/js.2019-MON-223 |
_version_ | 1783424250545176576 |
---|---|
author | Hoyos, Luis Leung, Karen Grogan, Tristan Abbott, David Chazenbalk, Gregorio Dumesic, Daniel |
author_facet | Hoyos, Luis Leung, Karen Grogan, Tristan Abbott, David Chazenbalk, Gregorio Dumesic, Daniel |
author_sort | Hoyos, Luis |
collection | PubMed |
description | Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and oligo-ovulation associated with insulin resistance (IR). Adipose-IR may underlie this PCOS phenotype and could contribute to IR by impairing insulin-mediated glucose uptake and/or lipogenesis, while diminishing insulin suppression of lipolysis. The present study examined whether adipose-IR, defined as the product of fasting circulating free fatty acid and insulin levels (1), was increased in normal-weight PCOS versus age-/BMI-balanced normo-androgenic ovulatory (control) women and, if so, whether it correlated with insulin sensitivity (Si) as measured by frequently-sampled intravenous glucose tolerance testing (FSIVGTT) and/or hyperandrogenism. Ten normal-weight PCOS women (by NIH criteria) and 18 controls (19-35 years; 19-25 kg/m(2)) of non-Hispanic Caucasian descent underwent serum hormone/metabolic measurements, FSIVGTT, total body dual-energy x-ray absorptiometry, and subcutaneous (SC) abdominal fat biopsy. Circulating hormone/metabolite levels, adipose-IR, Si, acute insulin response to glucose (AIRg), body fat distribution and adipocyte size distribution were compared between female types using Student’s t-test. Partial correlation coefficients examined associations between adipose-IR and outcome variables, adjusting for serum androgen levels. PCOS women exhibited greater serum LH, androstenedione (A4), total testosterone (T) and free (f) T levels than controls (P<0.05, all parameters), and demonstrated trends for increased abdominal adiposity (P=0.06) and serum triglyceride (TG) levels (P=0.09) with low-normal Si values. PCOS women also had greater (P=0.007) adipose-IR than controls, with a value of 29 pM/L*mM/L providing 94% specificity (95% CI 84%-100%) and 80% sensitivity (95% CI 55%-100%) in discriminating PCOS subjects from controls (AUC=0.81, 95% CI 0.61-1.00, P<0.001). In all women combined, adipose-IR negatively correlated with Si (P=0.01) and positively correlated with serum A4 (P=0.002), total T (P=0.004), fT (P=0.001) and fasting TG (P=0.001) levels as well as with AIRg (P=0.03) and percent small SC abdominal adipocytes (P=0.01). Relationships of adipose-IR with Si (P=0.04) and with serum TG (P=0.01) levels remained after adjusting for serum total T and fT levels, respectively, while the other correlations lost significance. Thus, in normal-weight PCOS women, adipose-IR is intimately linked with dyslipidemia and is associated with reduced Si in part through hyperandrogenism. Reference: Sondergaard E, et al. JCEM 2017;102:1193. Sources of Research Support: NIH Grants and Santa Monica Bay Woman’s Club. |
format | Online Article Text |
id | pubmed-6550739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-65507392019-06-13 MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome Hoyos, Luis Leung, Karen Grogan, Tristan Abbott, David Chazenbalk, Gregorio Dumesic, Daniel J Endocr Soc Reproductive Endocrinology Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and oligo-ovulation associated with insulin resistance (IR). Adipose-IR may underlie this PCOS phenotype and could contribute to IR by impairing insulin-mediated glucose uptake and/or lipogenesis, while diminishing insulin suppression of lipolysis. The present study examined whether adipose-IR, defined as the product of fasting circulating free fatty acid and insulin levels (1), was increased in normal-weight PCOS versus age-/BMI-balanced normo-androgenic ovulatory (control) women and, if so, whether it correlated with insulin sensitivity (Si) as measured by frequently-sampled intravenous glucose tolerance testing (FSIVGTT) and/or hyperandrogenism. Ten normal-weight PCOS women (by NIH criteria) and 18 controls (19-35 years; 19-25 kg/m(2)) of non-Hispanic Caucasian descent underwent serum hormone/metabolic measurements, FSIVGTT, total body dual-energy x-ray absorptiometry, and subcutaneous (SC) abdominal fat biopsy. Circulating hormone/metabolite levels, adipose-IR, Si, acute insulin response to glucose (AIRg), body fat distribution and adipocyte size distribution were compared between female types using Student’s t-test. Partial correlation coefficients examined associations between adipose-IR and outcome variables, adjusting for serum androgen levels. PCOS women exhibited greater serum LH, androstenedione (A4), total testosterone (T) and free (f) T levels than controls (P<0.05, all parameters), and demonstrated trends for increased abdominal adiposity (P=0.06) and serum triglyceride (TG) levels (P=0.09) with low-normal Si values. PCOS women also had greater (P=0.007) adipose-IR than controls, with a value of 29 pM/L*mM/L providing 94% specificity (95% CI 84%-100%) and 80% sensitivity (95% CI 55%-100%) in discriminating PCOS subjects from controls (AUC=0.81, 95% CI 0.61-1.00, P<0.001). In all women combined, adipose-IR negatively correlated with Si (P=0.01) and positively correlated with serum A4 (P=0.002), total T (P=0.004), fT (P=0.001) and fasting TG (P=0.001) levels as well as with AIRg (P=0.03) and percent small SC abdominal adipocytes (P=0.01). Relationships of adipose-IR with Si (P=0.04) and with serum TG (P=0.01) levels remained after adjusting for serum total T and fT levels, respectively, while the other correlations lost significance. Thus, in normal-weight PCOS women, adipose-IR is intimately linked with dyslipidemia and is associated with reduced Si in part through hyperandrogenism. Reference: Sondergaard E, et al. JCEM 2017;102:1193. Sources of Research Support: NIH Grants and Santa Monica Bay Woman’s Club. Endocrine Society 2019-04-30 /pmc/articles/PMC6550739/ http://dx.doi.org/10.1210/js.2019-MON-223 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Reproductive Endocrinology Hoyos, Luis Leung, Karen Grogan, Tristan Abbott, David Chazenbalk, Gregorio Dumesic, Daniel MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title | MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title_full | MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title_fullStr | MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title_full_unstemmed | MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title_short | MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome |
title_sort | mon-223 adipose insulin resistance in normal-weight women with polycystic ovary syndrome |
topic | Reproductive Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550739/ http://dx.doi.org/10.1210/js.2019-MON-223 |
work_keys_str_mv | AT hoyosluis mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome AT leungkaren mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome AT grogantristan mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome AT abbottdavid mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome AT chazenbalkgregorio mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome AT dumesicdaniel mon223adiposeinsulinresistanceinnormalweightwomenwithpolycysticovarysyndrome |